NCT00540878View on ClinicalTrials.gov

A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

April 30, 2007

Conditions

Osteoporosis

Interventions

DRUG

SB-751689 oral tablets (400 mg)

Trial Locations (1)

32127

GSK Investigational Site, Port Orange

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00540878 - A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women | Biotech Hunter | Biotech Hunter